The Therapeutic Goods Administration has advised that Apotex is recalling one batch of APO-Cabergoline 500mcg tablets "due to a packaging issue which could potentially lead to the product degrading over time in moist conditions".
The affected batch is MK0903 with an expiry date of Feb 2017, with the batch number displayed on the bottom flap of the carton as well as on the side of the bottle.
Apotex has written to pharmacists asking them to alert any patients using the product about the issue.
Consumers are being urged to return any tablets from the affected batch to the dispensing pharmacy for a refund or a replacement.
APO-Cabergoline is a medicine used to prevent the production of breast milk in women after giving birth, or to treat abnormally high levels of prolactin - tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Sep 16